National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
复制标题
DOI：
10.1016/j.jacl.2015.09.002
复制
发表时间：
2015-12-01
影响因子：
4.4
通讯作者：
Brown, W. Virgil
中科院分区：
文献类型：
--
作者：
Jacobson, Terry A.;Maki, Kevin C.;Brown, W. Virgil
由国家脂质协会召集的专家小组先前制定了一套共识建议，用于临床医学中以患者为中心的血脂异常管理（第1部分）。这些研究的指导原则是，降低致动脉粥样硬化胆固醇（非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇）的升高水平可降低动脉粥样硬化性心血管疾病的风险。这份文件代表了国家脂质协会建议的延续，该建议是由一个多元化的专家小组制定的，该专家小组审查了证据基础，并就以下主题提供了建议：（1）生活方式疗法;（2）有特殊考虑的群体，包括儿童和青少年、妇女、老年患者、某些族裔和种族群体、感染人类免疫缺陷病毒的患者，类风湿性关节炎患者，以及尽管使用他汀类药物和生活方式治疗但仍有剩余风险的患者;和（3）通过增加依从性和使用基于团队的协作护理来改善患者结局的策略。(C)2015年全国脂质协会。出版社：Elseiver Inc.
An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care. (C) 2015 National Lipid Association. Published by Elseiver Inc.